Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Evaluation of Neuromodulation for Tinnitus - Stage A3 (TENT-A3)

NCT05227365 is registered in ClinicalTrials.gov with Neuromod Devices Ltd. as lead sponsor.

NCT NCT05227365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05227365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Evaluation of Neuromodulation for Tinnitus - Stage A3 (TENT-A3)
Lead sponsor
Neuromod Devices Ltd.
Phase
Not applicable
Overall status
Completed
Start date
March 21, 2022
Completion date
October 25, 2022
Enrollment
112 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

tinnitus